Date Name Title Filing Type Shares Traded Price Total Held
Jun 20, 2006
Director
Director Form 4 Bona fide gift 219,801 -- 1,490
Jun 20, 2006
Director
Director Form 4 Bona fide gift 219,801 -- 219,801
Sep 18, 2013
Director, President & CEO
Director, President & CEO Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 218,389 $9.49 260,476
Sep 18, 2013
Director, President & CEO
Director, President & CEO Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 218,389 -- --
Dec 15, 2004
Director, Chief Exec Officer & President, Ten Percent Owner
Director, Chief Exec Officer & President, Ten Percent Owner Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 218,389 -- 218,389
Jun 24, 2021
Director, President and Chief Scientific
Director, President and Chief Scientific Form 4 Bona fide gift 211,585 -- 213,693
Jun 24, 2021
Director, President and Chief Scientific
Director, President and Chief Scientific Form 4 Bona fide gift 211,585 -- --
Dec 16, 2014
Director, President & CEO
Director, President & CEO Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 203,204 -- 203,204
Dec 13, 2013
Director, Pres Regeneron Labs
Director, Pres Regeneron Labs Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 203,204 -- 203,204
Aug 18, 2021
Director, President & CEO
Director, President & CEO Form 4 Open market or private sale of non-derivative or derivative security 200,000 $650.03 304,746

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.